IDXX IDEXX Laboratories Inc

For the fiscal year ended 31/12/2022: IDEXX Laboratories Inc's revenues increased by 4.73% and amounted to 3.37B. Net income decreased by 8.83% to 679.09M. Net assets decreased by 11.78% to 608.74M and EPS decreased from 8.60 to 8.03.